 | • レポートコード：MRC2Q12-03344 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、バルサルタンAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 バルサルタンAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 バルサルタンAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 バルサルタンAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのバルサルタンAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のバルサルタンAPIの売上および2028年までの予測に焦点を当てています。 バルサルタンAPIのグローバル主要企業には、Biophore India Pharmaceuticals、Zydus Lifesciences、Harman Finochem、Sun Pharmaceutical Industries、Teva Pharmaceutical Industries、Macleods Pharmaceuticals、MSN Life Sciences、Mylan Laboratories、Dr. Reddy's Laboratories、Ipca Laboratories、Divis Laboratories、Novartis、Lupin Ltd、Jubilant Generics、Alembic Pharmaceuticals、Aurobindo Pharma、Chromo Laboratories India、Hetero Labs Ltd、Krka、Zhejiang Tianyu Pharmaceutical、Zhejiang Second Pharma、Zhuhai Rundu Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 バルサルタンAPI市場は、タイプとアプリケーションによって区分されます。世界のバルサルタンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 純度99%以上、純度99%以下 【アプリケーション別セグメント】 錠剤、カプセル 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - バルサルタンAPI製品概要 - タイプ別市場（純度99%以上、純度99%以下） - アプリケーション別市場（錠剤、カプセル） - 調査の目的 ・エグゼクティブサマリー - 世界のバルサルタンAPI販売量予測2017-2028 - 世界のバルサルタンAPI売上予測2017-2028 - バルサルタンAPIの地域別販売量 - バルサルタンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別バルサルタンAPI販売量 - 主要メーカー別バルサルタンAPI売上 - 主要メーカー別バルサルタンAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（純度99%以上、純度99%以下） - バルサルタンAPIのタイプ別販売量 - バルサルタンAPIのタイプ別売上 - バルサルタンAPIのタイプ別価格 ・アプリケーション別市場規模（錠剤、カプセル） - バルサルタンAPIのアプリケーション別販売量 - バルサルタンAPIのアプリケーション別売上 - バルサルタンAPIのアプリケーション別価格 ・北米市場 - 北米のバルサルタンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のバルサルタンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのバルサルタンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のバルサルタンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のバルサルタンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のバルサルタンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のバルサルタンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のバルサルタンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのバルサルタンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のバルサルタンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Biophore India Pharmaceuticals、Zydus Lifesciences、Harman Finochem、Sun Pharmaceutical Industries、Teva Pharmaceutical Industries、Macleods Pharmaceuticals、MSN Life Sciences、Mylan Laboratories、Dr. Reddy's Laboratories、Ipca Laboratories、Divis Laboratories、Novartis、Lupin Ltd、Jubilant Generics、Alembic Pharmaceuticals、Aurobindo Pharma、Chromo Laboratories India、Hetero Labs Ltd、Krka、Zhejiang Tianyu Pharmaceutical、Zhejiang Second Pharma、Zhuhai Rundu Pharmaceutical ・産業チェーン及び販売チャネル分析 - バルサルタンAPIの産業チェーン分析 - バルサルタンAPIの原材料 - バルサルタンAPIの生産プロセス - バルサルタンAPIの販売及びマーケティング - バルサルタンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - バルサルタンAPIの産業動向 - バルサルタンAPIのマーケットドライバー - バルサルタンAPIの課題 - バルサルタンAPIの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Valsartan API Market
Due to the COVID-19 pandemic, the global Valsartan API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity Above 99% accounting for % of the Valsartan API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
China Valsartan API market size is valued at US$ million in 2021, while the US and Europe Valsartan API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Valsartan API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Valsartan API include Biophore India Pharmaceuticals, Zydus Lifesciences, Harman Finochem, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Macleods Pharmaceuticals, MSN Life Sciences, Mylan Laboratories and Dr. Reddy’s Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Valsartan API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Valsartan API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Valsartan API Scope and Segment
Valsartan API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Valsartan API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity Above 99%
Purity Below 99%
Segment by Application
Tablet
Capsule
By Company
Biophore India Pharmaceuticals
Zydus Lifesciences
Harman Finochem
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Macleods Pharmaceuticals
MSN Life Sciences
Mylan Laboratories
Dr. Reddy’s Laboratories
Ipca Laboratories
Divis Laboratories
Novartis
Lupin Ltd
Jubilant Generics
Alembic Pharmaceuticals
Aurobindo Pharma
Chromo Laboratories India
Hetero Labs Ltd
Krka
Zhejiang Tianyu Pharmaceutical
Zhejiang Second Pharma
Zhuhai Rundu Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Valsartan API Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity Above 99%
1.2.3 Purity Below 99%
1.3 Market by Application
1.3.1 Global Valsartan API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablet
1.3.3 Capsule
1.4 Study Objectives
1.5 Years Considered
2 Global Valsartan API Production
2.1 Global Valsartan API Production Capacity (2017-2028)
2.2 Global Valsartan API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Valsartan API Production by Region
2.3.1 Global Valsartan API Historic Production by Region (2017-2022)
2.3.2 Global Valsartan API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Valsartan API Sales in Volume & Value Estimates and Forecasts
3.1 Global Valsartan API Sales Estimates and Forecasts 2017-2028
3.2 Global Valsartan API Revenue Estimates and Forecasts 2017-2028
3.3 Global Valsartan API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Valsartan API Sales by Region
3.4.1 Global Valsartan API Sales by Region (2017-2022)
3.4.2 Global Sales Valsartan API by Region (2023-2028)
3.5 Global Valsartan API Revenue by Region
3.5.1 Global Valsartan API Revenue by Region (2017-2022)
3.5.2 Global Valsartan API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Valsartan API Production Capacity by Manufacturers
4.2 Global Valsartan API Sales by Manufacturers
4.2.1 Global Valsartan API Sales by Manufacturers (2017-2022)
4.2.2 Global Valsartan API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Valsartan API in 2021
4.3 Global Valsartan API Revenue by Manufacturers
4.3.1 Global Valsartan API Revenue by Manufacturers (2017-2022)
4.3.2 Global Valsartan API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Valsartan API Revenue in 2021
4.4 Global Valsartan API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Valsartan API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Valsartan API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Valsartan API Sales by Type
5.1.1 Global Valsartan API Historical Sales by Type (2017-2022)
5.1.2 Global Valsartan API Forecasted Sales by Type (2023-2028)
5.1.3 Global Valsartan API Sales Market Share by Type (2017-2028)
5.2 Global Valsartan API Revenue by Type
5.2.1 Global Valsartan API Historical Revenue by Type (2017-2022)
5.2.2 Global Valsartan API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Valsartan API Revenue Market Share by Type (2017-2028)
5.3 Global Valsartan API Price by Type
5.3.1 Global Valsartan API Price by Type (2017-2022)
5.3.2 Global Valsartan API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Valsartan API Sales by Application
6.1.1 Global Valsartan API Historical Sales by Application (2017-2022)
6.1.2 Global Valsartan API Forecasted Sales by Application (2023-2028)
6.1.3 Global Valsartan API Sales Market Share by Application (2017-2028)
6.2 Global Valsartan API Revenue by Application
6.2.1 Global Valsartan API Historical Revenue by Application (2017-2022)
6.2.2 Global Valsartan API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Valsartan API Revenue Market Share by Application (2017-2028)
6.3 Global Valsartan API Price by Application
6.3.1 Global Valsartan API Price by Application (2017-2022)
6.3.2 Global Valsartan API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Valsartan API Market Size by Type
7.1.1 North America Valsartan API Sales by Type (2017-2028)
7.1.2 North America Valsartan API Revenue by Type (2017-2028)
7.2 North America Valsartan API Market Size by Application
7.2.1 North America Valsartan API Sales by Application (2017-2028)
7.2.2 North America Valsartan API Revenue by Application (2017-2028)
7.3 North America Valsartan API Sales by Country
7.3.1 North America Valsartan API Sales by Country (2017-2028)
7.3.2 North America Valsartan API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Valsartan API Market Size by Type
8.1.1 Europe Valsartan API Sales by Type (2017-2028)
8.1.2 Europe Valsartan API Revenue by Type (2017-2028)
8.2 Europe Valsartan API Market Size by Application
8.2.1 Europe Valsartan API Sales by Application (2017-2028)
8.2.2 Europe Valsartan API Revenue by Application (2017-2028)
8.3 Europe Valsartan API Sales by Country
8.3.1 Europe Valsartan API Sales by Country (2017-2028)
8.3.2 Europe Valsartan API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Valsartan API Market Size by Type
9.1.1 Asia Pacific Valsartan API Sales by Type (2017-2028)
9.1.2 Asia Pacific Valsartan API Revenue by Type (2017-2028)
9.2 Asia Pacific Valsartan API Market Size by Application
9.2.1 Asia Pacific Valsartan API Sales by Application (2017-2028)
9.2.2 Asia Pacific Valsartan API Revenue by Application (2017-2028)
9.3 Asia Pacific Valsartan API Sales by Region
9.3.1 Asia Pacific Valsartan API Sales by Region (2017-2028)
9.3.2 Asia Pacific Valsartan API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Valsartan API Market Size by Type
10.1.1 Latin America Valsartan API Sales by Type (2017-2028)
10.1.2 Latin America Valsartan API Revenue by Type (2017-2028)
10.2 Latin America Valsartan API Market Size by Application
10.2.1 Latin America Valsartan API Sales by Application (2017-2028)
10.2.2 Latin America Valsartan API Revenue by Application (2017-2028)
10.3 Latin America Valsartan API Sales by Country
10.3.1 Latin America Valsartan API Sales by Country (2017-2028)
10.3.2 Latin America Valsartan API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Valsartan API Market Size by Type
11.1.1 Middle East and Africa Valsartan API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Valsartan API Revenue by Type (2017-2028)
11.2 Middle East and Africa Valsartan API Market Size by Application
11.2.1 Middle East and Africa Valsartan API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Valsartan API Revenue by Application (2017-2028)
11.3 Middle East and Africa Valsartan API Sales by Country
11.3.1 Middle East and Africa Valsartan API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Valsartan API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Biophore India Pharmaceuticals
12.1.1 Biophore India Pharmaceuticals Corporation Information
12.1.2 Biophore India Pharmaceuticals Overview
12.1.3 Biophore India Pharmaceuticals Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Biophore India Pharmaceuticals Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Biophore India Pharmaceuticals Recent Developments
12.2 Zydus Lifesciences
12.2.1 Zydus Lifesciences Corporation Information
12.2.2 Zydus Lifesciences Overview
12.2.3 Zydus Lifesciences Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Zydus Lifesciences Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zydus Lifesciences Recent Developments
12.3 Harman Finochem
12.3.1 Harman Finochem Corporation Information
12.3.2 Harman Finochem Overview
12.3.3 Harman Finochem Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Harman Finochem Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Harman Finochem Recent Developments
12.4 Sun Pharmaceutical Industries
12.4.1 Sun Pharmaceutical Industries Corporation Information
12.4.2 Sun Pharmaceutical Industries Overview
12.4.3 Sun Pharmaceutical Industries Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Sun Pharmaceutical Industries Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Sun Pharmaceutical Industries Recent Developments
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Corporation Information
12.5.2 Teva Pharmaceutical Industries Overview
12.5.3 Teva Pharmaceutical Industries Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Teva Pharmaceutical Industries Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Teva Pharmaceutical Industries Recent Developments
12.6 Macleods Pharmaceuticals
12.6.1 Macleods Pharmaceuticals Corporation Information
12.6.2 Macleods Pharmaceuticals Overview
12.6.3 Macleods Pharmaceuticals Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Macleods Pharmaceuticals Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Macleods Pharmaceuticals Recent Developments
12.7 MSN Life Sciences
12.7.1 MSN Life Sciences Corporation Information
12.7.2 MSN Life Sciences Overview
12.7.3 MSN Life Sciences Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 MSN Life Sciences Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 MSN Life Sciences Recent Developments
12.8 Mylan Laboratories
12.8.1 Mylan Laboratories Corporation Information
12.8.2 Mylan Laboratories Overview
12.8.3 Mylan Laboratories Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Mylan Laboratories Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Mylan Laboratories Recent Developments
12.9 Dr. Reddy’s Laboratories
12.9.1 Dr. Reddy’s Laboratories Corporation Information
12.9.2 Dr. Reddy’s Laboratories Overview
12.9.3 Dr. Reddy’s Laboratories Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Dr. Reddy’s Laboratories Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Dr. Reddy’s Laboratories Recent Developments
12.10 Ipca Laboratories
12.10.1 Ipca Laboratories Corporation Information
12.10.2 Ipca Laboratories Overview
12.10.3 Ipca Laboratories Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Ipca Laboratories Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Ipca Laboratories Recent Developments
12.11 Divis Laboratories
12.11.1 Divis Laboratories Corporation Information
12.11.2 Divis Laboratories Overview
12.11.3 Divis Laboratories Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Divis Laboratories Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Divis Laboratories Recent Developments
12.12 Novartis
12.12.1 Novartis Corporation Information
12.12.2 Novartis Overview
12.12.3 Novartis Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Novartis Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Novartis Recent Developments
12.13 Lupin Ltd
12.13.1 Lupin Ltd Corporation Information
12.13.2 Lupin Ltd Overview
12.13.3 Lupin Ltd Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Lupin Ltd Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Lupin Ltd Recent Developments
12.14 Jubilant Generics
12.14.1 Jubilant Generics Corporation Information
12.14.2 Jubilant Generics Overview
12.14.3 Jubilant Generics Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Jubilant Generics Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Jubilant Generics Recent Developments
12.15 Alembic Pharmaceuticals
12.15.1 Alembic Pharmaceuticals Corporation Information
12.15.2 Alembic Pharmaceuticals Overview
12.15.3 Alembic Pharmaceuticals Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Alembic Pharmaceuticals Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Alembic Pharmaceuticals Recent Developments
12.16 Aurobindo Pharma
12.16.1 Aurobindo Pharma Corporation Information
12.16.2 Aurobindo Pharma Overview
12.16.3 Aurobindo Pharma Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Aurobindo Pharma Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Aurobindo Pharma Recent Developments
12.17 Chromo Laboratories India
12.17.1 Chromo Laboratories India Corporation Information
12.17.2 Chromo Laboratories India Overview
12.17.3 Chromo Laboratories India Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Chromo Laboratories India Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Chromo Laboratories India Recent Developments
12.18 Hetero Labs Ltd
12.18.1 Hetero Labs Ltd Corporation Information
12.18.2 Hetero Labs Ltd Overview
12.18.3 Hetero Labs Ltd Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Hetero Labs Ltd Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Hetero Labs Ltd Recent Developments
12.19 Krka
12.19.1 Krka Corporation Information
12.19.2 Krka Overview
12.19.3 Krka Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Krka Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Krka Recent Developments
12.20 Zhejiang Tianyu Pharmaceutical
12.20.1 Zhejiang Tianyu Pharmaceutical Corporation Information
12.20.2 Zhejiang Tianyu Pharmaceutical Overview
12.20.3 Zhejiang Tianyu Pharmaceutical Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Zhejiang Tianyu Pharmaceutical Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Zhejiang Tianyu Pharmaceutical Recent Developments
12.21 Zhejiang Second Pharma
12.21.1 Zhejiang Second Pharma Corporation Information
12.21.2 Zhejiang Second Pharma Overview
12.21.3 Zhejiang Second Pharma Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 Zhejiang Second Pharma Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 Zhejiang Second Pharma Recent Developments
12.22 Zhuhai Rundu Pharmaceutical
12.22.1 Zhuhai Rundu Pharmaceutical Corporation Information
12.22.2 Zhuhai Rundu Pharmaceutical Overview
12.22.3 Zhuhai Rundu Pharmaceutical Valsartan API Sales, Price, Revenue and Gross Margin (2017-2022)
12.22.4 Zhuhai Rundu Pharmaceutical Valsartan API Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 Zhuhai Rundu Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Valsartan API Industry Chain Analysis
13.2 Valsartan API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Valsartan API Production Mode & Process
13.4 Valsartan API Sales and Marketing
13.4.1 Valsartan API Sales Channels
13.4.2 Valsartan API Distributors
13.5 Valsartan API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Valsartan API Industry Trends
14.2 Valsartan API Market Drivers
14.3 Valsartan API Market Challenges
14.4 Valsartan API Market Restraints
15 Key Finding in The Global Valsartan API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer